Related Experiment Video

Updated: Jan 21, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.9K

MicroRNA-93 promotes the tumorigenesis of osteosarcoma by targeting TIMP2

Hua Zhang1, Jidong Zhang1, Fanrui Meng1

  • 1Orthopaedic Surgery, Chengwu People's Hospital, Heze 274200, Shandong Province, P.R. China.

Bioscience Reports
|August 7, 2019
PubMed

Insights

MicroRNA-93 (miR-93) promotes osteosarcoma (OS) development by suppressing tissue inhibitor of matrix metalloproteinase 2 (TIMP2). This study reveals miR-93 as an oncogene and TIMP2 as a tumor suppressor in OS progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Osteosarcoma (OS) is a primary bone cancer predominantly affecting adolescents and young adults.
  • MicroRNA (miRNA) dysregulation plays a significant role in OS carcinogenesis.
  • Understanding the roles of specific miRNAs and their targets is crucial for OS research.

Purpose of the Study:

  • To investigate the involvement of microRNA-93 (miR-93) and tissue inhibitor of matrix metalloproteinase 2 (TIMP2) in osteosarcoma development.
  • To determine the relationship between miR-93, TIMP2, and OS patient prognosis.
  • To elucidate the functional interaction between miR-93 and TIMP2 in OS cells.

Main Methods:

  • Real-time PCR and western blot were used to quantify miR-93 and TIMP2 levels in OS cell lines and patient tissues.
  • Functional assays (overexpression, knockdown, mutation, gain, and loss experiments) assessed the impact of miR-93 and TIMP2 on OS cell behavior.
  • Analysis correlated miR-93 and TIMP2 expression with patient survival data.

Main Results:

  • miR-93 levels were elevated, while TIMP2 levels were decreased in OS cells and tissues compared to normal controls.
  • High miR-93 expression and low TIMP2 expression correlated with poor patient survival and prognosis.
  • miR-93 promoted OS cell viability, invasion, and epithelial-mesenchymal transition (EMT), whereas TIMP2 exhibited inhibitory effects.
  • miR-93 directly targeted and downregulated TIMP2, and TIMP2 overexpression reversed miR-93's oncogenic effects.

Conclusions:

  • miR-93 acts as an oncogene in osteosarcoma, promoting tumor progression by downregulating TIMP2.
  • TIMP2 functions as a tumor suppressor in osteosarcoma, counteracting the oncogenic effects of miR-93.
  • The miR-93/TIMP2 axis represents a potential therapeutic target for osteosarcoma treatment.
Keywords:
EMTMiR-93TIMP2osteosarcoma

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.2K
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

9.3K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

3.8K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
2.0K